Introducing The Consensus Ecosystem: The Industry’s First Unified Revenue Engine Built to Accelerate Deal Velocity
ATLANTA, Jan. 8, 2026 /PRNewswire/ — Consensus, the world’s leading Demo Automation Platform, today announced the launch of the Consensus Ecosystem,... Read more.
Complement Therapeutics Announces FDA Fast Track Designation for CTx001 for the Treatment of Geographic Atrophy Secondary to AMD
FDA Fast Track designation has been granted to CTx001 for Geographic Atrophy secondary to Age-related Macular Degeneration CTx001 is an investigational AAV-based... Read more.
Foresee Pharmaceuticals announces Global Licensing Agreement for MMP-12 Inhibitors with Primevera Therapeutics LLC
Foresee licenses exclusive global rights related to its MMP-12 inhibitor programs to Primevera Therapeutics, LLC. Foresee will receive a 10 million USD upfront payment,... Read more.
China’s AGI Pioneer and Leader Z.ai Listed on Hong Kong Stock Exchange
SHANGHAI, Jan. 8, 2026 /PRNewswire/ — Qiming Venture Partners’ portfolio company Z.ai (formerly known as Zhipu AI), a pioneer and leader inartificial... Read more.
Invitation to Autoliv’s Q4, 2025 Earnings Call
STOCKHOLM , Jan. 8, 2026 /PRNewswire/ — Autoliv Inc., plans to publish its Financial Report for the fourth quarter 2025 on Friday, January 30, 2026 at 12:00... Read more.
Tiiny AI Launches Pocket-Size Personal AI Computer, Drawing Strong Media Attention at CES
Tiiny AI Pocket Lab brings private, offline AI computing — including 120B-parameter models — to individuals LAS VEGAS, Jan. 8, 2026 /PRNewswire/ — Tiiny... Read more.
Shoplazza Launches Fulfillment by Shoplazza (FBS) for Global Merchants
Amid ongoing cross-border logistics challenges, Shoplazza introduces FBS, a secure, integrated fulfillment solution designed to support global e-commerce growth.... Read more.
ACEMAGIC Showcases Next-Generation AI and Gaming Mini PCs at CES 2026
LAS VEGAS, Jan. 8, 2026 /PRNewswire/ — ACEMAGIC unveiled its latest Mini PC lineup at CES 2026, highlighting significant advancements in local AI computing,... Read more.
STORM Therapeutics and AlidaBio Announce Strategic Collaboration to Accelerate Development of Cancer Therapies Targeting RNA Modifications
CAMBRIDGE, England and SAN DIEGO, Jan. 8, 2026 /PRNewswire/ — STORM Therapeutics Ltd. (STORM), the clinical stage company pioneering cellular reprogramming... Read more.
Seasoned biotherapeutics leader Thomas J. Farrell joins NanoSyrinx as CEO to advance Nanosyringe-enabled intracellular medicines
– 25+ years of biotherapeutics leadership, including serving as founding CEO of two NASDAQ-listed companies and securing over $500 million in funding – Expertise... Read more.